A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Servier
Jazz Pharmaceuticals
Day One Biopharmaceuticals, Inc.
Orbus Therapeutics, Inc.
Oblato, Inc.
Celgene
Istari Oncology, Inc.
Candel Therapeutics, Inc.
Candel Therapeutics, Inc.
OncoSynergy, Inc.
Vanquish Oncology, Inc.
Quadriga Biosciences, Inc.
Biogen
Tocagen Inc.
Tocagen Inc.
Pfizer
Tocagen Inc.
Tocagen Inc.
Tocagen Inc.
Amgen
Exelixis
Angiochem Inc
Novartis
Daiichi Sankyo
INSYS Therapeutics Inc
INSYS Therapeutics Inc
INSYS Therapeutics Inc
TransMolecular
Pharmacyclics LLC.
MediGene